pyrazole has been researched along with dihydropyridines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bull, DJ; Cooper, K; Fray, MJ; Parry, MJ; Stefaniak, MH | 1 |
| Lagunes, I; Padrón, JM; Patel, DM; Patel, HM; Puerta, A; Rajani, DP; Sharma, MG; Vala, RM | 1 |
2 other study(ies) available for pyrazole and dihydropyridines
| Article | Year |
|---|---|
Novel antagonists of platelet-activating factor. 2. Synthesis and structure-activity relationships of potent and long-acting heterofused [1,5]benzodiazepine and [1,4]diazepine derivatives of 2-methyl-1-phenylimidazo[4,5-c]pyridine.
Topics: Animals; Azepines; Benzene; Benzodiazepines; Dihydropyridines; Dogs; Imidazoles; In Vitro Techniques; Mice; Platelet Activating Factor; Platelet Aggregation Inhibitors; Pyrazoles; Pyridines; Rabbits; Structure-Activity Relationship; X-Ray Diffraction | 1995 |
Hydroxyl alkyl ammonium ionic liquid assisted green and one-pot regioselective access to functionalized pyrazolodihydropyridine core and their pharmacological evaluation.
Topics: Ammonium Compounds; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Candida albicans; Cell Line; Cell Proliferation; Dihydropyridines; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Escherichia coli; Humans; Hydroxyl Radical; Ionic Liquids; Microbial Sensitivity Tests; Molecular Structure; Pyrazoles; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship | 2019 |